<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2016-04-06 10:54:29Estrogens Steroids Endocrine system Reproduction Chemistry Androstenediol 3-Androstanediol Androstane 4-Androstenedione Androstenedione Androsterone Epiandrosterone |
Add to Reading List |
WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST | WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LISTDocID: 1ruc9 - View Document |
 | WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LISTDocID: 1mJ5p - View Document |
![AROMASIN® (exemestane tablets) NDA[removed]S-006 October 4, 2005 S-006 Approved Labeling EBC Indication](https://www.pdfsearch.io/img/d4d88db0b10edef86ba642672276cdda.jpg "AROMASIN® (exemestane tablets) NDA[removed]S-006 October 4, 2005 S-006 Approved Labeling EBC Indication") | AROMASIN® (exemestane tablets) NDA[removed]S-006 October 4, 2005 S-006 Approved Labeling EBC IndicationDocID: FQ3l - View Document |
 | PDF DocumentDocID: xUnx - View Document |
![December[removed]INTRODUCTION This report is the quarterly summary of all data reported within the specified data-reporting period for Quarter 4, 2013. The attached tables provide the certification profiles for the distrib](https://www.pdfsearch.io/img/088f5b689232d10186959da18f2eb999.jpg "December[removed]INTRODUCTION This report is the quarterly summary of all data reported within the specified data-reporting period for Quarter 4, 2013. The attached tables provide the certification profiles for the distrib") | December[removed]INTRODUCTION This report is the quarterly summary of all data reported within the specified data-reporting period for Quarter 4, 2013. The attached tables provide the certification profiles for the distribDocID: jL1i - View Document |